Pfizer EBIT 2010-2024 | PFE

Pfizer EBIT for the quarter ending December 31, 2024 was $2.347B, a 154.73% decline year-over-year.

  • Pfizer 2024 EBIT was 12.411B, a 870.37% increase from 2023.
  • Pfizer 2023 EBIT was 1.279B, a 96.43% decline from 2022.
  • Pfizer 2022 EBIT was 35.789B, a 84.17% increase from 2021.

EBIT can be defined as earnings before interest and taxes.

Pfizer EBIT 2010-2024 | PFE

  • Pfizer 2024 EBIT was 12.411B, a 870.37% increase from 2023.
  • Pfizer 2023 EBIT was 1.279B, a 96.43% decline from 2022.
  • Pfizer 2022 EBIT was 35.789B, a 84.17% increase from 2021.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$823.1B
Johnson & Johnson (JNJ)$380.1B
Novo Nordisk (NVO)$374.3B
AbbVie (ABBV)$348.4B
Roche Holding AG (RHHBY)$259.5B
Novartis AG (NVS)$218.5B
Merck (MRK)$216.5B
Sanofi (SNY)$136B
Bayer (BAYRY)$22B
Innoviva (INVA)$1.1B